Adient (NYSE:ADNT – Get Free Report) had its target price lifted by research analysts at UBS Group from $15.00 to $25.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price objective indicates a potential upside of 12.36% from the stock’s previous close.
Other research analysts have also recently issued reports about the stock. Citigroup assumed coverage on shares of Adient in a report on Wednesday, April 23rd. They issued a “neutral” rating and a $14.00 price target on the stock. Morgan Stanley dropped their target price on shares of Adient from $17.00 to $16.00 and set an “underweight” rating on the stock in a research note on Monday, May 19th. Barclays downgraded shares of Adient from an “equal weight” rating to a “negative” rating in a research note on Tuesday, April 15th. Bank of America boosted their price target on Adient from $15.00 to $17.50 and gave the company an “underperform” rating in a report on Monday, June 16th. Finally, Wall Street Zen downgraded Adient from a “buy” rating to a “hold” rating in a report on Saturday, June 14th. Three analysts have rated the stock with a sell rating and seven have given a hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $18.56.
Check Out Our Latest Research Report on ADNT
Adient Price Performance
Adient (NYSE:ADNT – Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.33. The firm had revenue of $3.61 billion during the quarter, compared to analyst estimates of $3.39 billion. Adient had a positive return on equity of 7.70% and a negative net margin of 1.86%. Adient’s quarterly revenue was down 3.7% compared to the same quarter last year. During the same period last year, the company earned $0.54 EPS. Equities research analysts anticipate that Adient will post 1.76 earnings per share for the current year.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. HITE Hedge Asset Management LLC lifted its position in Adient by 184.2% during the first quarter. HITE Hedge Asset Management LLC now owns 2,320,103 shares of the company’s stock valued at $29,837,000 after acquiring an additional 1,503,817 shares during the last quarter. Hotchkis & Wiley Capital Management LLC increased its position in shares of Adient by 22.4% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 4,500,736 shares of the company’s stock worth $57,879,000 after purchasing an additional 823,638 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Adient during the 4th quarter valued at $11,395,000. Millennium Management LLC boosted its position in shares of Adient by 2,039.0% in the 4th quarter. Millennium Management LLC now owns 610,312 shares of the company’s stock worth $10,516,000 after purchasing an additional 581,779 shares in the last quarter. Finally, Federated Hermes Inc. boosted its position in shares of Adient by 68,173.6% in the 1st quarter. Federated Hermes Inc. now owns 524,341 shares of the company’s stock worth $6,743,000 after purchasing an additional 523,573 shares in the last quarter. 92.44% of the stock is owned by institutional investors.
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Stories
- Five stocks we like better than Adient
- How to Invest in the Best Canadian StocksĀ
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- Differences Between Momentum Investing and Long Term Investing
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- 3 Healthcare Dividend Stocks to Buy
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.